10,671 Shares in Inspire Medical Systems, Inc. $INSP Purchased by Versor Investments LP

Versor Investments LP acquired a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 10,671 shares of the company’s stock, valued at approximately $1,385,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC boosted its holdings in Inspire Medical Systems by 14.6% during the second quarter. Farther Finance Advisors LLC now owns 603 shares of the company’s stock worth $78,000 after buying an additional 77 shares in the last quarter. Allianz Asset Management GmbH boosted its holdings in Inspire Medical Systems by 1.6% during the first quarter. Allianz Asset Management GmbH now owns 5,000 shares of the company’s stock worth $796,000 after buying an additional 78 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in Inspire Medical Systems by 27.2% during the first quarter. Smartleaf Asset Management LLC now owns 454 shares of the company’s stock worth $71,000 after buying an additional 97 shares in the last quarter. New York State Teachers Retirement System boosted its holdings in Inspire Medical Systems by 0.5% during the second quarter. New York State Teachers Retirement System now owns 21,490 shares of the company’s stock worth $2,789,000 after buying an additional 100 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its holdings in Inspire Medical Systems by 4.7% during the first quarter. PNC Financial Services Group Inc. now owns 2,419 shares of the company’s stock worth $385,000 after buying an additional 109 shares in the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Insider Buying and Selling at Inspire Medical Systems

In other news, CFO Richard Buchholz sold 11,000 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $93.39, for a total value of $1,027,290.00. Following the completion of the transaction, the chief financial officer owned 44,867 shares of the company’s stock, valued at $4,190,129.13. The trade was a 19.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 4.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

INSP has been the topic of a number of research analyst reports. Royal Bank Of Canada reissued an “outperform” rating and set a $150.00 price objective on shares of Inspire Medical Systems in a report on Friday, October 10th. Wall Street Zen cut shares of Inspire Medical Systems from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. Truist Financial cut their target price on shares of Inspire Medical Systems from $125.00 to $90.00 and set a “hold” rating for the company in a research report on Wednesday, October 15th. Lake Street Capital set a $150.00 target price on shares of Inspire Medical Systems and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Finally, Morgan Stanley cut their target price on shares of Inspire Medical Systems from $200.00 to $182.00 and set an “overweight” rating for the company in a research report on Tuesday, July 15th. Seven investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $141.13.

Inspire Medical Systems Price Performance

NYSE:INSP opened at $71.97 on Friday. The firm has a 50 day simple moving average of $80.76 and a 200-day simple moving average of $113.66. The firm has a market cap of $2.13 billion, a PE ratio of 41.60, a P/E/G ratio of 2.23 and a beta of 1.16. Inspire Medical Systems, Inc. has a 1-year low of $70.77 and a 1-year high of $216.01.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings data on Monday, August 4th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.23. The business had revenue of $217.09 million during the quarter, compared to analyst estimates of $214.50 million. Inspire Medical Systems had a net margin of 6.17% and a return on equity of 10.38%. The company’s revenue was up 10.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.32 earnings per share. Inspire Medical Systems has set its FY 2025 guidance at 0.400-0.500 EPS. As a group, sell-side analysts expect that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Inspire Medical Systems announced that its board has initiated a share repurchase plan on Monday, August 11th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 8.6% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board believes its shares are undervalued.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.